Risk factors and clinical prediction models for osteoporosis in pre-dialysis chronic kidney disease patients

References

• Abdalbary M, Sobh M, Elnagar S, et al. Management of osteoporosis in patients with chronic kidney disease. Osteoporos Int. 2022;33(11):2259–2274. doi:10.1007/s00198-022-06462-3.
   PubMed Web of Science ®Google Scholar
• Aggarwal HK, Jain D, Yadav S, et al. Bone mineral density in patients with predialysis chronic kidney disease. Ren Fail. 2013;35(8):1105–1111. doi:10.3109/0886022X.2013.815102.
   PubMed Web of Science ®Google Scholar
• Mittalhenkle A, Gillen DL, Stehman-Breen CO. Increased risk of mortality associated with hip fracture in the dialysis population. Am J Kidney Dis. 2004;44(4):672–679. doi:10.1016/S0272-6386(04)00958-8.
   PubMed Web of Science ®Google Scholar
• Tentori F, McCullough K, Kilpatrick RD, et al. High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int. 2014;85(1):166–173. doi:10.1038/ki.2013.279.
   PubMed Web of Science ®Google Scholar
• Vilaca T, Salam S, Schini M, et al. Risks of hip and nonvertebral fractures in patients with CKD G3a-G5D: a systematic review and meta-analysis. Am J Kidney Dis. 2020;76(4):521–532. doi:10.1053/j.ajkd.2020.02.450.
   PubMed Web of Science ®Google Scholar
• Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Mineral Res. 2007;22(3):465–475. doi:10.1359/jbmr.061113.
   PubMed Web of Science ®Google Scholar
• Hyun YY, Lee K-B, Han SH, et al. Risk factors and renal outcomes of low bone mineral density in patients with non-dialysis chronic kidney disease. Osteoporos Int. 2020;31(12):2373–2382. doi:10.1007/s00198-020-05531-9.
   PubMed Web of Science ®Google Scholar
• KDIGO. Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7(1):1–59. doi:10.1016/j.kisu.2017.04.001.
   Web of Science ®Google Scholar
• Jadoul M, Albert JM, Akiba T, et al. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study. Kidney Int. 2006;70(7):1358–1366. doi:10.1038/sj.ki.5001754.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Fukagawa M. Uremic toxicity and bone in CKD. J Nephrol. 2017;30(5):623–627. doi:10.1007/s40620-017-0406-x.
   PubMed Web of Science ®Google Scholar
• Danese MD, Kim J, Doan QV, et al. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis. 2006;47(1):149–156. doi:10.1053/j.ajkd.2005.09.024.
   PubMed Web of Science ®Google Scholar
• Chen W, Bushinsky DA. Chronic kidney disease: KDIGO CKD-MBD guideline update: evolution in the face of uncertainty. Nat Rev Nephrol. 2017;13(10):600–602. doi:10.1038/nrneph.2017.118.
   PubMed Web of Science ®Google Scholar
• Burton JO, Goldsmith DJ, Ruddock N, et al. Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD. BMC Nephrol. 2018;19(1):240. doi:10.1186/s12882-018-1037-8.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin, D. and Calcium, The National Academies Collection: reports funded by National Institutes of Health, in Dietary Reference Intakes for Calcium and Vitamin D. A.C. Ross, et al. Editors. 2011, National Academies Press (US) Copyright © 2011, National Academy of Sciences.: Washington (DC).
   Google Scholar
• Chen C, Lu FC. The guidelines for prevention and control of overweight and obesity in chinese adults. Biomed Environ Sci. 2004;17(Suppl):1–36.
   Google Scholar
• Wu H-H, Wu B, Zhang S-J, et al. Establishing age-adjusted trabecular bone score curves using dual-energy X-ray absorptiometry in chinese women and men: a cross-sectional study. Quant Imaging Med Surg. 2023;13(4):2478–2485. doi:10.21037/qims-22-550.
   PubMed Web of Science ®Google Scholar
• Nickolas TL, Stein EM, Dworakowski E, et al. Rapid cortical bone loss in patients with chronic kidney disease. J Bone Mineral Res. 2013;28(8):1811–1820. doi:10.1002/jbmr.1916.
   PubMed Web of Science ®Google Scholar
• Silva BC, et al. Catabolic and anabolic actions of parathyroid hormone on the skeleton. J Endocrinol Investig. 2011;34(10):801–810.
   PubMed Web of Science ®Google Scholar
• Elliott MJ, James MT, Quinn RR, et al. Estimated GFR and fracture risk: a population-based study. Clin J Am Soc Nephrol: CJASN. 2013;8(8):1367–1376. doi:10.2215/CJN.09130912.
   PubMed Web of Science ®Google Scholar
• Fujita Y, Iki M, Tamaki J, et al. Renal function and bone mineral density in community-dwelling elderly japanese men: the fujiwara-kyo osteoporosis risk in men (FORMEN) study. Bone. 2013;56(1):61–66. doi:10.1016/j.bone.2013.05.004.
   PubMed Web of Science ®Google Scholar
• Iimori S, et al. Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients–a single-center cohort study. Nephrol Dialysis Transplant. 2012;27(1):345–351.
   PubMed Web of Science ®Google Scholar
• Naylor KL, Garg AX, Zou G, et al. Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol: CJASN. 2015;10(4):646–653. doi:10.2215/CJN.06040614.
   PubMed Web of Science ®Google Scholar
• Carvalho C, Magalhães J, Neto R, et al. Cortical bone analysis in a predialysis population: a comparison with a dialysis population. J Bone Miner Metab. 2017;35(5):513–521. doi:10.1007/s00774-016-0781-8.
   PubMed Web of Science ®Google Scholar
• Kuo TR, Chen CH. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomark Res. 2017;5(1):18. doi:10.1186/s40364-017-0097-4.
   PubMedGoogle Scholar
• Camacho PM, et al. American association of clinical endocrinologists/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocrine Pract. 2020;26(Suppl 1):1–46.
   Google Scholar
• Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton. Trends Endocrinol Metab. 2012;23(11):576–581. doi:10.1016/j.tem.2012.03.008.
   PubMed Web of Science ®Google Scholar
• Qian D, Wang Z-F, Cheng Y-C, et al. Early menopause may associate with a higher risk of CKD and all-cause mortality in postmenopausal women: an analysis of NHANES, 1999-2014. Front Med (Lausanne). 2022;9:823835. doi:10.3389/fmed.2022.823835.
   PubMed Web of Science ®Google Scholar
• Li Q, Zheng D, Lin H, et al. High circulating Follicle-stimulating hormone level is a potential risk factor for renal dysfunction in Post-Menopausal women. Front Endocrinol (Lausanne). 2021;12:627903. doi:10.3389/fendo.2021.627903.
   PubMed Web of Science ®Google Scholar
• Kim H-L, Park IY, Choi JM, et al. A decline in renal function is associated with loss of bone mass in korean postmenopausal women with mild renal dysfunction. J Korean Med Sci. 2011;26(3):392–398. doi:10.3346/jkms.2011.26.3.392.
   PubMed Web of Science ®Google Scholar
• Sheng Y-H, Chen J-H, Chiou J-M, et al. Association of renal function and menopausal status with bone mineral density in Middle-aged women. Sci Rep. 2015;5(1):14956. doi:10.1038/srep14956.
   PubMedGoogle Scholar
• Chen H, Lips P, Vervloet MG, et al. Association of renal function with bone mineral density and fracture risk in the longitudinal aging study amsterdam. Osteoporos Int. 2018;29(9):2129–2138. doi:10.1007/s00198-018-4592-8.
   PubMed Web of Science ®Google Scholar
• Kaji H, Yamauchi M, Yamaguchi T, et al. Mild renal dysfunction is a risk factor for a decrease in bone mineral density and vertebral fractures in japanese postmenopausal women. J Clin Endocrinol Metab. 2010;95(10):4635–4642. doi:10.1210/jc.2010-0099.
   PubMed Web of Science ®Google Scholar
• Shapses SA, Riedt CS. Bone, body weight, and weight reduction: what are the concerns? J Nutr. 2006;136(6):1453–1456. doi:10.1093/jn/136.6.1453.
   PubMed Web of Science ®Google Scholar
• Watts NB, Camacho PM, Lewiecki EM, et al. American association of clinical endocrinologists/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocrine Pract. 2021;27(4):379–380. doi:10.1016/j.eprac.2021.02.001.
   PubMed Web of Science ®Google Scholar
• Yoshimura N, Muraki S, Oka H, et al. Do sarcopenia and/or osteoporosis increase the risk of frailty? A 4-year observation of the second and third ROAD study surveys. Osteoporos Int. 2018;29(10):2181–2190. doi:10.1007/s00198-018-4596-4.
   PubMed Web of Science ®Google Scholar
• Ahmadi S-F, Zahmatkesh G, Ahmadi E, et al. Association of body mass index with clinical outcomes in non-dialysis-dependent chronic kidney disease: a systematic review and meta-analysis. Cardiorenal Med. 2015;6(1):37–49. doi:10.1159/000437277.
   PubMed Web of Science ®Google Scholar
• Fassio A, Idolazzi L, Rossini M, et al. The obesity paradox and osteoporosis. Eat Weight Disord. 2018;23(3):293–302. doi:10.1007/s40519-018-0505-2.
   PubMed Web of Science ®Google Scholar
• Prieto-Alhambra D, Premaor MO, Fina Avilés F, et al. The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women. J Bone Miner Res. 2012;27(2):294–300. doi:10.1002/jbmr.1466.
   PubMed Web of Science ®Google Scholar
• Premaor MO, Compston JE, Fina Avilés F, et al. The association between fracture site and obesity in men: a population-based cohort study. J Bone Miner Res. 2013;28(8):1771–1777. doi:10.1002/jbmr.1878.
   PubMed Web of Science ®Google Scholar
• Watts NB. Insights from the global longitudinal study of osteoporosis in women (GLOW). Nat Rev Endocrinol. 2014;10(7):412–422. doi:10.1038/nrendo.2014.55.
   PubMed Web of Science ®Google Scholar
• Marques IDB, Araújo MJCLN, Graciolli FG, et al. Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities. Osteoporos Int. 2017;28(5):1675–1683. doi:10.1007/s00198-017-3956-9.
   PubMed Web of Science ®Google Scholar
• Haarhaus M, et al. Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD. Nat Rev Nephrol. 2017;13(7):429–442.
   PubMed Web of Science ®Google Scholar
• Garrett G, Sardiwal S, Lamb EJ, et al. PTH–a particularly tricky hormone: why measure it at all in kidney patients? Clin J Am Soc Nephrol: CJASN. 2013;8(2):299–312. doi:10.2215/CJN.09580911.
   PubMed Web of Science ®Google Scholar
• Coen G. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Nephrol Dialysis Transplant. 1998;13(9):2294–2302. doi:10.1093/ndt/13.9.2294.
   PubMed Web of Science ®Google Scholar
• Moore C, Yee J, Malluche H, et al. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients. Clin J Am Soc Nephrol: CJASN. 2009;4(9):1484–1493. doi:10.2215/CJN.01770408.
   PubMed Web of Science ®Google Scholar
• Ureña P, Hruby M, Ferreira A, et al. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol: JASN. 1996;7(3):506–512. doi:10.1681/ASN.V73506.
   PubMed Web of Science ®Google Scholar
• Jørgensen HS, Winther S, Bøttcher M, et al. Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study. BMC Nephrol. 2017;18(1):284. doi:10.1186/s12882-017-0692-5.
   PubMedGoogle Scholar
• Ureña P, De Vernejoul MC. Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int. 1999;55(6):2141–2156. doi:10.1046/j.1523-1755.1999.00461.x.
   PubMed Web of Science ®Google Scholar
• Sprague SM, Bellorin-Font E, Jorgetti V, et al. Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am J Kidney Dis. 2016;67(4):559–566. doi:10.1053/j.ajkd.2015.06.023.
   PubMed Web of Science ®Google Scholar
• Fishbane S, Hazzan AD, Jhaveri KD, et al. Bone parameters and risk of hip and femur fractures in patients on hemodialysis. CJASN. 2016;11(6):1063–1072. doi:10.2215/CJN.09280915.
   PubMed Web of Science ®Google Scholar
• Malluche HH, Davenport DL, Cantor T, et al. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis. Clin J Am Soc Nephrol: CJASN. 2014;9(7):1254–1262. doi:10.2215/CJN.09470913.
   PubMed Web of Science ®Google Scholar
• Atsumi K, Kushida K, Yamazaki K, et al. Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis. 1999;33(2):287–293. doi:10.1016/S0272-6386(99)70302-1.
   PubMed Web of Science ®Google Scholar
• Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis. 2000;36(6):1115–1121. doi:10.1053/ajkd.2000.19812.
   PubMed Web of Science ®Google Scholar
• Jansz TT, Goto NA, van Ballegooijen AJ, et al. The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone. Osteoporos Int. 2020;31(3):515–524. doi:10.1007/s00198-019-05187-0.
   PubMed Web of Science ®Google Scholar
• Kim SM, Choi HJ, Lee JP, et al. Prevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease. J Renal Nutr. 2014;24(1):20–25. doi:10.1053/j.jrn.2013.07.003.
   PubMed Web of Science ®Google Scholar
• LaClair RE, Hellman RN, Karp SL, et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005;45(6):1026–1033. doi:10.1053/j.ajkd.2005.02.029.
   PubMed Web of Science ®Google Scholar
• LeBlanc ES, Zakher B, Daeges M, et al. Screening for vitamin D deficiency: a systematic review for the U.S. Preventive services task force. Ann Intern Med. 2015;162(2):109–122. doi:10.7326/M14-1659.
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Willett WC, Orav EJ, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367(1):40–49. doi:10.1056/NEJMoa1109617.
   PubMed Web of Science ®Google Scholar
• Yadav AK, Kumar V, Kumar V, et al. The effect of vitamin D supplementation on bone metabolic markers in chronic kidney disease. J Bone Miner Res. 2018;33(3):404–409. doi:10.1002/jbmr.3314.
   PubMed Web of Science ®Google Scholar